Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors.

Styczyński J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S, Mikulska M, Gil L, Cordonnier C, Ljungman P, Averbuch D, Cesaro S, de la Camara R, Baldomero H, Bader P, Basak G, Bonini C, Duarte R, Dufour C, Kuball J, Lankester A, Montoto S, Nagler A, Snowden JA, Kröger N, Mohty M, Gratwohl A; Infectious Diseases Working Party EBMT.

Bone Marrow Transplant. 2019 Aug 27. doi: 10.1038/s41409-019-0624-z. [Epub ahead of print]

PMID:
31455899
2.

Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT.

Cesaro S, Tridello G, van der Werf S, Bader P, Sociè G, Ljungman P, McQuaker G, Giardino S, Uckan-Cetinkaya D, Anagnostopoulos A, Ozdogu H, Schots R, Jindra P, Ladetto M, Schroyens W, Mikulska M, Styczynski J.

Bone Marrow Transplant. 2019 Aug 21. doi: 10.1038/s41409-019-0644-8. [Epub ahead of print]

PMID:
31435035
3.

Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT.

Styczynski J, Tridello G, Gil L, Ljungman P, Mikulska M, Ward KN, Cordonnier C, de la Camara R, Averbuch D, Knelange N, Socié G, Chevallier P, Blaise D, Yakoub-Agha I, Forcade E, Cornelissen J, Maertens J, Petersen E, Nguyen-Quoc S, Veelken H, Schaap N, Passweg J, Michallet M, Fegueux N, Deconinck E, Russell N, Basak G, Bader P, Montoto S, Kröger N, Cesaro S; Infectious Diseases Working Party EBMT.

Bone Marrow Transplant. 2019 Jul 30. doi: 10.1038/s41409-019-0627-9. [Epub ahead of print]

PMID:
31363166
4.

2017 ECIL 7 vaccine guidelines.

Cordonnier C, Mikulska M, Einarsdottir S, Cesaro S, Ljungman P; ECIL vaccine group.

Lancet Infect Dis. 2019 Jul;19(7):694-695. doi: 10.1016/S1473-3099(19)30277-4. No abstract available.

PMID:
31250818
5.

Use of colistin in adult patients: a cross-sectional study.

Giacobbe DR, Saffioti C, Losito AR, Rinaldi M, Aurilio C, Bolla C, Boni S, Borgia G, Carannante N, Cassola G, Ceccarelli G, Corcione S, Gasperina DD, De Rosa FG, Dentone C, Di Bella S, Di Lauria N, Feasi M, Fiore M, Fossati S, Franceschini E, Gori A, Granata G, Grignolo S, Grossi PA, Guadagnino G, Lagi F, Maraolo AE, Marinò V, Mazzitelli M, Mularoni A, Oliva A, Pace MC, Parisini A, Patti F, Petrosillo N, Pota V, Raffaelli F, Rossi M, Santoro A, Tascini C, Torti C, Trecarichi EM, Venditti M, Viale P, Signori A, Bassetti M, Del Bono V, Giannella M, Mikulska M, Tumbarello M, Viscoli C; SITA GIOVANI, (young investigators group of the Società Italiana Terapia Antinfettiva), the COLI-CROSS study group.

J Glob Antimicrob Resist. 2019 Jun 14. pii: S2213-7165(19)30153-5. doi: 10.1016/j.jgar.2019.06.009. [Epub ahead of print]

PMID:
31207379
6.

Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study.

Albasanz-Puig A, Gudiol C, Parody R, Tebe C, Akova M, Araos R, Bote A, Brunel AS, Calik S, Drgona L, García E, Hemmati P, Herrera F, Ibrahim KY, Isler B, Kanj S, Kern W, Maestro de la Calle G, Manzur A, Marin JI, Márquez-Gómez I, Martín-Dávila P, Mikulska M, Montejo JM, Montero M, Morales HMP, Morales I, Novo A, Oltolini C, Peghin M, Del Pozo JL, Puerta-Alcalde P, Ruiz-Camps I, Sipahi OR, Tilley R, Yáñez L, Gomes MZR, Carratalà J; IRONIC study group.

BMJ Open. 2019 May 24;9(5):e025744. doi: 10.1136/bmjopen-2018-025744.

7.

Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy.

Furfaro E, Signori A, Di Grazia C, Dominietto A, Raiola AM, Aquino S, Ghiggi C, Ghiso A, Ungaro R, Angelucci E, Viscoli C, Mikulska M.

J Antimicrob Chemother. 2019 Aug 1;74(8):2341-2346. doi: 10.1093/jac/dkz188.

PMID:
31119272
8.

The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.

Schmidt-Hieber M, Tridello G, Ljungman P, Mikulska M, Knelange N, Blaise D, Socié G, Volin L, Blijlevens N, Fegueux N, Yakoub-Agha I, Forcade E, Maertens J, Chevallier P, Passweg J, Cornelissen J, Russell N, Craddock C, Bourhis JH, Marchand T, Reményi P, Cahn JY, Michallet M, Montoto S, Kröger N, Glaß B, Styczynski J.

Ann Hematol. 2019 Jul;98(7):1755-1763. doi: 10.1007/s00277-019-03669-z. Epub 2019 Apr 16.

PMID:
30993417
9.

Fulminant Hepatitis Associated With Echovirus 25 During Treatment With Ocrelizumab for Multiple Sclerosis.

Nicolini LA, Canepa P, Caligiuri P, Mikulska M, Novi G, Viscoli C, Uccelli A.

JAMA Neurol. 2019 Jul 1;76(7):866-867. doi: 10.1001/jamaneurol.2019.0522. No abstract available.

PMID:
30958517
10.

Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients.

Timsit JF, Sonneville R, Kalil AC, Bassetti M, Ferrer R, Jaber S, Lanternier F, Luyt CE, Machado F, Mikulska M, Papazian L, Pène F, Poulakou G, Viscoli C, Wolff M, Zafrani L, Van Delden C.

Intensive Care Med. 2019 May;45(5):573-591. doi: 10.1007/s00134-019-05597-y. Epub 2019 Mar 25. Review.

PMID:
30911807
11.

Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery.

Giacobbe DR, Corcione S, Salsano A, Del Puente F, Mornese Pinna S, De Rosa FG, Mikulska M, Santini F, Viscoli C.

Expert Opin Pharmacother. 2019 Apr;20(6):751-772. doi: 10.1080/14656566.2019.1574753. Epub 2019 Feb 20. Review.

PMID:
30785333
12.

Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.

Mikulska M, Furfaro E, De Carolis E, Drago E, Pulzato I, Borghesi ML, Zappulo E, Raiola AM, Grazia CD, Del Bono V, Cittadini G, Angelucci E, Sanguinetti M, Viscoli C.

Med Mycol. 2019 Feb 7. doi: 10.1093/mmy/myz002. [Epub ahead of print]

PMID:
30753590
13.

Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7).

Mikulska M, Cesaro S, de Lavallade H, Di Blasi R, Einarsdottir S, Gallo G, Rieger C, Engelhard D, Lehrnbecher T, Ljungman P, Cordonnier C; European Conference on Infections in Leukaemia group.

Lancet Infect Dis. 2019 Jun;19(6):e188-e199. doi: 10.1016/S1473-3099(18)30601-7. Epub 2019 Feb 8. Review. Erratum in: Lancet Infect Dis. 2019 Apr;19(4):e109.

PMID:
30744964
14.

Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7).

Cordonnier C, Einarsdottir S, Cesaro S, Di Blasi R, Mikulska M, Rieger C, de Lavallade H, Gallo G, Lehrnbecher T, Engelhard D, Ljungman P; European Conference on Infections in Leukaemia group.

Lancet Infect Dis. 2019 Jun;19(6):e200-e212. doi: 10.1016/S1473-3099(18)30600-5. Epub 2019 Feb 8. Review.

PMID:
30744963
15.

A survey on incidence and management of adenovirus infection after allogeneic HSCT.

Cesaro S, Berger M, Tridello G, Mikulska M, Ward KN, Ljungman P, Van Der Werf S, Averbuch D, Styczynski J; Infectious Disease Working Party of EBMT.

Bone Marrow Transplant. 2019 Aug;54(8):1275-1280. doi: 10.1038/s41409-018-0421-0. Epub 2018 Dec 13.

PMID:
30546071
16.

Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia.

Giacobbe DR, Signori A, Tumbarello M, Ungaro R, Sarteschi G, Furfaro E, Mikulska M, Sanguinetti M, Posteraro B, Losito AR, De Pascale G, Del Bono V, Viscoli C.

Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):413-417. doi: 10.1007/s10096-018-3441-1. Epub 2018 Nov 30.

PMID:
30506332
17.

Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria.

Giacobbe DR, Mikulska M, Viscoli C.

Expert Rev Clin Pharmacol. 2018 Dec;11(12):1219-1236. doi: 10.1080/17512433.2018.1549487. Epub 2018 Dec 6. Review.

PMID:
30444147
18.

Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab.

Zappulo E, Nicolini LA, Di Grazia C, Dominietto A, Lamparelli T, Gualandi F, Caligiuri P, Bruzzone B, Angelucci E, Viscoli C, Mikulska M.

Infection. 2019 Feb;47(1):59-65. doi: 10.1007/s15010-018-1214-5. Epub 2018 Sep 19.

PMID:
30232604
19.

Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report.

Lapucci C, Gualandi F, Mikulska M, Palmeri S, Mancardi G, Uccelli A, Laroni A.

Mult Scler Relat Disord. 2018 Nov;26:52-54. doi: 10.1016/j.msard.2018.09.006. Epub 2018 Sep 11.

PMID:
30223229
20.

Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature.

Tatarelli P, Fornaro G, Del Bono V, Nicolini LA, Raiola AM, Gualandi F, Varaldo R, Di Muccio T, Gramiccia M, Gradoni L, Angelucci E, Viscoli C, Mikulska M.

J Infect Chemother. 2018 Dec;24(12):990-994. doi: 10.1016/j.jiac.2018.05.008. Epub 2018 Aug 8. Review.

PMID:
30098915
21.

Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies.

Furfaro E, Giacobbe DR, Del Bono V, Signori A, Guolo F, Minetto P, Clavio M, Ballerini F, Gobbi M, Viscoli C, Mikulska M.

Mycoses. 2018 Sep;61(9):650-655. doi: 10.1111/myc.12787. Epub 2018 Jun 13.

PMID:
29693758
22.
23.

De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period.

Gustinetti G, Raiola AM, Varaldo R, Galaverna F, Gualandi F, Del Bono V, Bacigalupo A, Angelucci E, Viscoli C, Mikulska M.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1721-1726. doi: 10.1016/j.bbmt.2018.03.018. Epub 2018 Mar 22.

24.
25.

Fluoroquinolone prophylaxis during neutropenia: what can we expect nowadays?

Mikulska M, Cordonnier C.

Clin Microbiol Infect. 2018 Jul;24(7):678-679. doi: 10.1016/j.cmi.2018.02.031. Epub 2018 Mar 13. No abstract available.

26.

Protective environment for hematopoietic cell transplant (HSCT) recipients: The Infectious Diseases Working Party EBMT analysis of global recommendations on health-care facilities.

Styczynski J, Tridello G, Donnelly JP, Iacobelli S, Hoek J, Mikulska M, Aljurf M, Gil L, Cesaro S.

Bone Marrow Transplant. 2018 Sep;53(9):1131-1138. doi: 10.1038/s41409-018-0141-5. Epub 2018 Mar 13.

PMID:
29535381
27.

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52).

Mikulska M, Lanini S, Gudiol C, Drgona L, Ippolito G, Fernández-Ruiz M, Salzberger B.

Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S71-S82. doi: 10.1016/j.cmi.2018.02.003. Epub 2018 Feb 12. Review.

28.

Management of chronic viral hepatitis in the hematological patient.

Nicolini LA, Zappulo E, Viscoli C, Mikulska M.

Expert Rev Anti Infect Ther. 2018 Mar;16(3):227-241. doi: 10.1080/14787210.2018.1438264. Epub 2018 Feb 18. Review.

PMID:
29415584
29.

Re: "Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis" by Horita et al.

Averbuch D, Orasch C, Mikulska M, Livermore DM, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M, Calandra T, Cordonnier C; ECIL4 antibacterial group, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN.

Clin Microbiol Infect. 2018 Jun;24(6):662-663. doi: 10.1016/j.cmi.2018.01.012. Epub 2018 Feb 2. No abstract available.

30.

Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT.

Cesaro S, Crocchiolo R, Tridello G, Knelange N, Van Lint MT, Koc Y, Ciceri F, Gülbas Z, Tischer J, Afanasyev B, Bruno B, Castagna L, Blaise D, Mohty M, Irrera G, Diez-Martin JL, Pierelli L, Pioltelli P, Arat M, Delia M, Fagioli F, Ehninger G, Aljurf M, Carella AM, Ozdogu H, Mikulska M, Ljungman P, Nagler A, Styczynski J.

Bone Marrow Transplant. 2018 Apr;53(4):422-430. doi: 10.1038/s41409-017-0016-1. Epub 2018 Jan 12.

PMID:
29330396
31.

Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.

Giacobbe DR, Del Bono V, Viscoli C, Mikulska M.

Expert Rev Anti Infect Ther. 2017 Dec;15(12):1101-1112. doi: 10.1080/14787210.2017.1401467. Epub 2017 Nov 20. Review.

PMID:
29125373
32.

Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.

Mikulska M, Averbuch D, Tissot F, Cordonnier C, Akova M, Calandra T, Ceppi M, Bruzzi P, Viscoli C; European Conference on Infections in Leukemia (ECIL).

J Infect. 2018 Jan;76(1):20-37. doi: 10.1016/j.jinf.2017.10.009. Epub 2017 Oct 25.

PMID:
29079323
33.

Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.

Averbuch D, Tridello G, Hoek J, Mikulska M, Akan H, Yanez San Segundo L, Pabst T, Özçelik T, Klyasova G, Donnini I, Wu D, Gülbas Z, Zuckerman T, Botelho de Sousa A, Beguin Y, Xhaard A, Bachy E, Ljungman P, de la Camara R, Rascon J, Ruiz Camps I, Vitek A, Patriarca F, Cudillo L, Vrhovac R, Shaw PJ, Wolfs T, O'Brien T, Avni B, Silling G, Al Sabty F, Graphakos S, Sankelo M, Sengeloev H, Pillai S, Matthes S, Melanthiou F, Iacobelli S, Styczynski J, Engelhard D, Cesaro S.

Clin Infect Dis. 2017 Nov 13;65(11):1819-1828. doi: 10.1093/cid/cix646.

34.

Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy.

Giacobbe DR, Del Bono V, Mikulska M, Gustinetti G, Marchese A, Mina F, Signori A, Orsi A, Rudello F, Alicino C, Bonalumi B, Morando A, Icardi G, Beltramini S, Viscoli C; San Martino Antimicrobial Stewardship Group.

Infection. 2017 Dec;45(6):929. doi: 10.1007/s15010-017-1068-2.

PMID:
28983883
35.

Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.

Mikulska M, Raiola AM, Galaverna F, Balletto E, Borghesi ML, Varaldo R, Gualandi F, Giannoni L, Pastori G, Giacobbe DR, Signori A, Del Bono V, Viscoli C, Bacigalupo A, Angelucci E.

Biol Blood Marrow Transplant. 2018 Jan;24(1):109-118. doi: 10.1016/j.bbmt.2017.08.024. Epub 2017 Aug 30.

36.

Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy.

Giacobbe DR, Del Bono V, Mikulska M, Gustinetti G, Marchese A, Mina F, Signori A, Orsi A, Rudello F, Alicino C, Bonalumi B, Morando A, Icardi G, Beltramini S, Viscoli C; San Martino Antimicrobial Stewardship Group.

Infection. 2017 Dec;45(6):849-856. doi: 10.1007/s15010-017-1063-7. Epub 2017 Aug 30. Erratum in: Infection. 2017 Dec;45(6):929.

PMID:
28856589
37.

Surface structure changes of pathological placenta tissue observed using scanning electron microscopy - a pilot study.

Bobiński R, Pielesz A, Waksmańska W, Sarna E, Ulman-Włodarz I, Kania J, Mikulska M, Turbiarz A.

Acta Biochim Pol. 2017;64(3):533-535. doi: 10.18388/abp.2017_1528. Epub 2017 Aug 12.

38.

Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units.

Giacobbe DR, Mikulska M, Tumbarello M, Furfaro E, Spadaro M, Losito AR, Mesini A, De Pascale G, Marchese A, Bruzzone M, Pelosi P, Mussap M, Molin A, Antonelli M, Posteraro B, Sanguinetti M, Viscoli C, Del Bono V; ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva).

Crit Care. 2017 Jul 10;21(1):176. doi: 10.1186/s13054-017-1763-5.

39.

No report on Zika virus infection in EBMT registry: Infectious Diseases Working Party statement.

Styczynski J, Hoek J, Knelange N, Mikulska M, Cesaro S, Aljurf M, Gil L.

Bone Marrow Transplant. 2017 Sep;52(9):1345-1346. doi: 10.1038/bmt.2017.145. Epub 2017 Jul 10. No abstract available.

PMID:
28692024
40.

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper.

Sarmati L, Andreoni M, Antonelli G, Arcese W, Bruno R, Coppola N, Gaeta GB, Galli M, Girmenia C, Mikulska M, Pane F, Perno CF, Picardi M, Puoti M, Rambaldi A, Svicher V, Taliani G, Gentile G.

Clin Microbiol Infect. 2017 Dec;23(12):935-940. doi: 10.1016/j.cmi.2017.06.023. Epub 2017 Jun 29.

41.

The dietary composition of women who delivered preterm and full-term infants.

Waksmańska W, Bobiński R, Ulman-Włodarz I, Pielesz A, Mikulska M.

Appl Nurs Res. 2017 Jun;35:13-17. doi: 10.1016/j.apnr.2017.02.013. Epub 2017 Feb 3.

PMID:
28532720
42.

Good tolerability of high dose colistin-based therapy in patients with haematological malignancies.

Grignolo S, Tatarelli P, Guolo F, Minetto P, Rivoli G, Guardo D, Del Bono V, Varaldo R, Gualandi F, Ballerini F, Raiola A, Gobbi M, Viscoli C, Mikulska M.

Infection. 2017 Aug;45(4):505-511. doi: 10.1007/s15010-017-1010-7. Epub 2017 Mar 28.

PMID:
28353153
43.

Lower sensitivity of serum (1,3)-β-d-glucan for the diagnosis of candidaemia due to Candida parapsilosis.

Mikulska M, Giacobbe DR, Furfaro E, Mesini A, Marchese A, Del Bono V, Viscoli C.

Clin Microbiol Infect. 2016 Jul;22(7):646.e5-8. doi: 10.1016/j.cmi.2016.05.020. Epub 2016 May 30.

44.

Multidrug-resistant bacteria in hematology patients: emerging threats.

Tatarelli P, Mikulska M.

Future Microbiol. 2016 Jun;11:767-80. doi: 10.2217/fmb-2015-0014. Epub 2016 May 19. Review.

PMID:
27196948
45.

Bloodstream infections in neutropenic cancer patients: A practical update.

Gustinetti G, Mikulska M.

Virulence. 2016 Apr 2;7(3):280-97. doi: 10.1080/21505594.2016.1156821. Review.

46.

Blood donors screening for blood born viruses in Poland.

Grabarczyk P, Kopacz A, Sulkowska E, Kubicka-Russel D, Mikulska M, Brojer E, Łętowska M.

Przegl Epidemiol. 2015;69(3):473-7, 591-5. English, Polish.

47.

The ins and outs of maternal-fetal fatty acid metabolism.

Bobiński R, Mikulska M.

Acta Biochim Pol. 2015;62(3):499-507. doi: 10.18388/abp.2015_1067. Epub 2015 Sep 8. Review.

48.

Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients.

Balletto E, Mikulska M.

Mediterr J Hematol Infect Dis. 2015 Jul 1;7(1):e2015045. doi: 10.4084/MJHID.2015.045. eCollection 2015. Review.

49.

Assessment of the diet components of pregnant women as predictors of risk of preterm birth and born baby with low birth weight.

Bobiński R, Mikulska M, Mojska H, Ulman-Wodarz I, Sodowska P.

Ginekol Pol. 2015 Apr;86(4):292-9.

PMID:
26117989
50.

Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil.

Giacobbe DR, Esteves P, Bruzzi P, Mikulska M, Furfaro E, Mesini A, Tatarelli P, Grignolo S, Viscoli C, Colombo AL, Del Bono V.

Clin Microbiol Infect. 2015 Oct;21(10):954.e9-17. doi: 10.1016/j.cmi.2015.06.002. Epub 2015 Jun 10.

Supplemental Content

Loading ...
Support Center